Author

M Chen

Institution: Bristol-Myers Squibb (United States)

Observed institution: Bristol-Myers Squibb (United States)

OpenAlex ID: A5041983132

P07: Results From the Cc-220-mm-001 Dose-expansion Phase of Iberdomide Plus Dexamethasone in Patients With Relapsed/refractory Multiple Myeloma

2022 · N. W. C. J van de Donk, R Popat, et al. · HemaSphere · 7

Works count: 1

Citation count: 7

H-index: 1

I10-index: